In addition to preventing CRMP2 hyperphosphorylation (Figure 3) and preserving CRMP2 binding to Miro 2, Drp1, and Mitofusin 2 (Figure 5), (S)-LCM restored mitochondrial motility and morphology in AD neurons (Figure 6). This evidence concerns the gene MFN2 and Alzheimer disease.